QuidelOrtho

Update in progress

QDEL (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

QuidelOrtho Corporation delivers diagnostic testing solutions through four units: Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics. Labs provides clinical chemistry and immunoassay instruments and tests to evaluate health, monitor disease, and assess organ function; Transfusion Medicine offers immunohematology and donor screening tools for blood typing and infectious disease screening; Point of Care delivers rapid, on-site tests; Molecular Diagnostics offers PCR systems and sample-to-result assays for infectious diseases. The company sells directly and through distributors worldwide. Founded 1979; headquartered in San Diego, California.

Company score

Sentiment: 0.26; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.48; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.22; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.12; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.25; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.26; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive